Incyte Corp INCY:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
after hours iconAfter Hours: Last | 04/20/21 EDT
84.57UNCH (UNCH)
Volume
28,950
Close
84.57quote price arrow up+1.90 (+2.30%)
Volume
706,656
52 week range
75.52 - 110.36

...

Loading . . .
  • Open82.90
  • Day High84.64
  • Day Low82.90
  • Prev Close84.57
  • 52 Week High110.36
  • 52 Week High Date07/07/20
  • 52 Week Low75.52
  • 52 Week Low Date03/04/21

Key Stats

  • Market Cap18.595B
  • Shares Out219.88M
  • 10 Day Average Volume1.16M
  • Dividend-
  • Dividend Yield-
  • Beta0.80
  • YTD % Change-2.77

KEY STATS

  • Open82.90
  • Day High84.64
  • Day Low82.90
  • Prev Close84.57
  • 52 Week High110.36
  • 52 Week High Date07/07/20
  • 52 Week Low75.52
  • 52 Week Low Date03/04/21
  • Market Cap18.595B
  • Shares Out219.88M
  • 10 Day Average Volume1.16M
  • Dividend-
  • Dividend Yield-
  • Beta0.80
  • YTD % Change-2.77

RATIOS/PROFITABILITY

  • EPS (TTM)-1.39
  • P/E (TTM)-60.65
  • Fwd P/E (NTM)26.35
  • EBITDA (MRQ)-145.683M
  • ROE (MRQ)-11.35%
  • Revenue (MRQ)2.667B
  • Gross Margin (MRQ)95.88%
  • Net Margin (MRQ)-11.09%
  • Debt To Equity (MRQ)1.33%

EVENTS

  • Earnings Date05/04/2021
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest From Incyte Corp

There is no recent news for this security.

Profile

MORE
Incyte Corporation is a biopharmaceutical company focused on the discovery, development and commercialization of therapeutics. Its portfolio includes compounds in various stages, ranging from preclinical to late-stage development, and commercialized products, such as JAKAFI (ruxolitinib) and ICLUSIG (ponatinib). JAKAFI (ruxolitinib) is indicated for the treatment of patients with intermediate or high risk myelofibrosis (MF) and for the treatment of patients with polycythemia...
Herve Hoppenot
Chairman
Christiana Stamoulis
Chief Financial Officer
Maria Pasquale
Executive Vice President
Paula Swain
Executive Vice President
Steven Stein M.D.
Executive Vice President
Address
1801 Augustine Cut off
Wilmington, DE
19803-4404
United States

Top Peers

SYMBOLLASTCHG%CHG
CRL
Charles River Laboratories International Inc
322.37-2.22-0.68%
EXAS
Exact Sciences Corp
125.62-1.91-1.50%
NVZMY
Novozymes A/S
66.18+0.63+0.95%
PRAH
PRA Health Sciences Inc
162.68+1.35+0.84%
SGEN
Seagen Inc
144.76+0.75+0.52%